170 related articles for article (PubMed ID: 33881940)
21. APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
Wang Q; Wang B; Zhang W; Zhang T; Liu Q; Jiao X; Ye J; Hao Y; Gao Q; Ma G; Hao C; Cui B
Arch Biochem Biophys; 2024 May; 755():109983. PubMed ID: 38561035
[TBL] [Abstract][Full Text] [Related]
22. Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells.
Roche J; Ramé C; Reverchon M; Mellouk N; Cornuau M; Guerif F; Froment P; Dupont J
Biol Reprod; 2016 Nov; 95(5):104. PubMed ID: 27683264
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
26. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
27. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
Ge F; Tie W; Zhang J; Zhu Y; Fan Y
J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
[TBL] [Abstract][Full Text] [Related]
28. Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
Wang X; Wang J; Yu M
Comput Math Methods Med; 2022; 2022():1902289. PubMed ID: 35345518
[TBL] [Abstract][Full Text] [Related]
29. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
31. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
[TBL] [Abstract][Full Text] [Related]
32. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
33. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
35. High DHCR7 Expression Predicts Poor Prognosis for Cervical Cancer.
Zou J; Liu S; Long J; Yan B
Comput Math Methods Med; 2022; 2022():8383885. PubMed ID: 36164611
[TBL] [Abstract][Full Text] [Related]
36. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():765569. PubMed ID: 35154268
[No Abstract] [Full Text] [Related]
37. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
38. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract][Full Text] [Related]
39. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
40. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
